Canberra Hospital

Garran ACT 2605

2 studies enrolling now · 7 studies all time

What they study most

Advanced Non-Small Cell Lung Cancer, Atherosclerotic Cardiovascular Disease (ASCVD), Chronic Kidney Disease (CKD), Endometrial Cancer, Fallopian Tube Cancer, Follicular Lymphoma (FL), Immunoglobulin A Nephropathy, Marginal Zone Lymphoma, Metastatic Non-Small Cell Lung Cancer, Non Hodgkin Lymphoma, Non-Small Cell Lung Cancer, Platinum-resistant Ovarian Cancer

Studies at this site

• Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7 — Recruiting now
• Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER — Recruiting now
• The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) — Running, not enrolling
• Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN) — Running, not enrolling
• Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) — Stopped early
• Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC — Running, not enrolling
• Phase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL) — Stopped early